Volume 17, Issue 4 pp. 976-983
Original Article

Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease

Ashwin N. Ananthakrishnan MD, MPH

Corresponding Author

Ashwin N. Ananthakrishnan MD, MPH

Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin

Gastrointestinal Unit, Massachusetts General Hospital, 165 Cambridge Street, 9th Floor, Boston, MA 02114Search for more papers by this author
Emily L. McGinley MS, MPH

Emily L. McGinley MS, MPH

Division of Epidemiology, Medical College of Wisconsin, Milwaukee, Wisconsin

Search for more papers by this author
Kia Saeian MD, MSc, Epi

Kia Saeian MD, MSc, Epi

Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin

Search for more papers by this author
David G. Binion MD

David G. Binion MD

Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Search for more papers by this author
First published: 07 September 2010
Citations: 18

This work was presented in part as an oral presentation at Digestive Disease Week 2010, New Orleans, LA.

Author contributions: Study concept and design (Ananthakrishnan, Binion); acquisition of data (McGinley); analysis and interpretation of data (Ananthakrishnan, McGinley, Saeian, Binion); drafting of the article (Ananthakrishnan); critical revision of the article for important intellectual content (Ananthakrishnan, McGinley, Saeian, Binion); statistical analysis (Ananthakrishnan, McGinley).

Abstract

Background:

Clostridium difficile has emerged as an important pathogen in patients with inflammatory bowel disease (IBD) and is associated with increased morbidity and mortality. No studies have examined the temporal change in severity of C. difficile infection (CDI) complicating IBD.

Methods:

Using data from the Nationwide Inpatient Sample, we identified all IBD-related hospitalizations during the years 1998, 2004, and 2007 and examined hospitalizations with a coexisting diagnosis of C. difficile. We compared the absolute outcomes of in-hospital mortality and colectomy in the C. difficile-IBD cohort during these timepoints, and also examined these outcomes relative to non-C. difficile IBD controls during each corresponding year.

Results:

During 1998, 2004, and 2007, approximately 1.4%, 2.3%, and 2.9% of all IBD hospitalizations nationwide were complicated by CDI (P < 0.001). The absolute mortality in the C. difficile-IBD cohort increased from 5.9%–7.2% (P = 0.052) with a nonsignificant increase in colectomy rate from 3.8%–4.5% between 1998 and 2007. Compared to non-C. difficile IBD controls, there was an increase in the relative mortality risk associated with C. difficile from 1998 (odds ratio [OR] 2.38, 95% confidence interval [CI]: 1.52–3.72) to 2007 (OR 3.38, 95% CI: 2.66–4.29) (P = 0.15) with a significant increase in total colectomy odds from 1998 (OR 1.39, 95% CI: 0.81–2.37) to 2007 (OR 2.51, 95% CI: 1.90–3.34) (P = 0.03).

Conclusion:

There has been a temporal increase nationwide in CDI complicating IBD hospitalizations. The excess morbidity associated with C. difficile infection in hospitalized IBD patients has increased between 1998 and 2007. (Inflamm Bowel Dis 2011;)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.